Patent · US Active

Diagnosis and therapy of cancer using SGP28-related molecules

US8101372B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

Latency, LLC · US

Inventors

Rene S. Hubert · Los Angeles, US
Arthur B. Raitano · Los Angeles, US
Daniel Afar · Santa Monica, US
Steve Chappell Mitchell · Santa Monica, US
Mary Faris · Los Angeles, US
Aya Jakobovits · Beverly Hills, US

Key dates

Filing date	Dec 23, 2008
Grant date	Jan 24, 2012
Priority date	—
Expiry date	Dec 23, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods and compositions for the diagnosis and therapy of prostate cancer which utilize isolated polynucleotides corresponding to the human SGP28 gene, proteins encoded by the SGP28 gene and fragments thereof, and antibodies capable of specifically recognizing and binding to SGP28 proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.